Comparison

LILRA3 Blocking Peptide (C-term)

Item no. ABC-BP20443b
Manufacturer Abcepta
Amount 500 ug
Category
Type Peptides
Format Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Specific against other
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Similar products LILRA3, ILT6, LIR-4, LIR4, Leukocyte immunoglobulin-like receptor subfamily A member 3, CD85 antigen-like family member E, CD85e, Immunoglobulin-like transcript 6, Leukocyte immunoglobulin-like receptor 4, ILT-6, Monocyte inhibitory receptor HM43/HM31
Available
Primary Accession
Q8N6C8
Bio Background
May act as soluble receptor for class I MHC antigens.
Bio References
Zhang Z., et al. Protein Sci. 13:2819-2824(2004).
Arm J.P., et al. J. Immunol. 159:2342-2349(1997).
Borges L., et al. J. Immunol. 159:5192-5196(1997).
Norman P.J., et al. Immunogenetics 55:165-171(2003).
Gene ID
11026
Gene Name
LILRA3
Subtitle
Synthetic peptide

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close